Cargando…
Chemoprevention of prostate cancer in men with high-grade prostatic intraepithelial neoplasia (HGPIN): a systematic review and adjusted indirect treatment comparison
BACKGROUND: High-grade prostatic intraepithelial neoplasia (HGPIN) is the precursor or premalignant form of prostate cancer. At least 30% patients with a confirmed HGPIN will develop prostate cancer within 1 year after repeated biopsy. HGPIN patients are the appropriate at-risk population for chemop...
Autores principales: | Cui, Kang, Li, Xiangnan, Du, Yabing, Tang, Xiance, Arai, Seiji, Geng, Yiwei, Xi, Ying, Xu, Han, Zhou, Yue, Ma, Wang, Zhang, Tengfei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5482687/ https://www.ncbi.nlm.nih.gov/pubmed/28415774 http://dx.doi.org/10.18632/oncotarget.16230 |
Ejemplares similares
-
Why do we keep reporting high-grade prostatic intraepithelial neoplasia (HGPIN)?
Publicado: (2016) -
Prostate Cancer Chemoprevention Targeting Men with High-Grade Prostatic Intraepithelial Neoplasia (HGPIN) and Atypical Small Acinar Proliferation (ASAP): Model for Trial Design and Outcome Measures
por: Kumar, Nagi, et al.
Publicado: (2012) -
Risk of prostate cancer after detection of isolated high-grade prostatic intraepithelial neoplasia (HGPIN) on extended core needle biopsy: a UK hospital experience
por: Singh, Paras B, et al.
Publicado: (2009) -
High-Grade Prostatic Intraepithelial Neoplasia
por: Klink, Joseph C, et al.
Publicado: (2012) -
Efficacy and safety of regorafenib as beyond second-line therapy in patients with metastatic colorectal cancer: an adjusted indirect meta-analysis and systematic review
por: Wu, Yinying, et al.
Publicado: (2020)